In this second installment of MedPage Today's virtual roundtable series on pediatric low-grade glioma, moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, is joined once ...

MedPage Today brought together three expert leaders for a virtual roundtable discussion on pediatric low-grade glioma. Moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, ...

The acquisition is expected to boost Servier’s position in pediatric low-grade glioma treatments. ・This acquisition aligns ...

These tumors are less likely to spread to surrounding tissues than higher-grade tumors, so they often have better outcomes. In the past, pediatric gliomas were classified into low-grade and high-grade ...

If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with relapsed or ...

Pediatric gliomas are also known as childhood gliomas. They’re a type of tumor that can develop in a child’s central nervous system (CNS), including their brain or spinal cord. Gliomas are tumors that ...

Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A This study enrolled 40 patients with mLGG ...

Please provide your email address to receive an email when new articles are posted on . Two-thirds of patients with relapsed pediatric low-grade glioma treated with tovorafenib responded to therapy, ...

How Do I Take Ojemda? Ojemda is an oral medicine that is taken by mouth one time each week on the same day of the week. Ojemda can be taken with or without food. Ojemda comes as a tablet that is ...

Please provide your email address to receive an email when new articles are posted on . Maximal resection of low-grade glioma shortly after diagnosis may lead to longer survival, according to research ...

Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in children.